Dulaglutide: Difference between revisions
Content deleted Content added
reflist |
+template |
||
| Line 3: | Line 3: | ||
==References== |
==References== |
||
{{reflist}} |
{{reflist}} |
||
{{Oral hypoglycemics and insulin analogs |state=expanded}} |
|||
Revision as of 13:00, 30 April 2014
Dulaglutide is an investigational GLP-1 glucagon-like peptide 1 receptor agonist (GLP-1 agonist), that can be used once-weekly.[1][2]